Improving antithrombotic treatment in patients after myocardial infarction
- PMID: 13678866
- DOI: 10.1016/S0140-6736(03)14296-1
Improving antithrombotic treatment in patients after myocardial infarction
Comment on
-
Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial.Lancet. 2003 Sep 6;362(9386):789-97. doi: 10.1016/S0140-6736(03)14287-0. Lancet. 2003. PMID: 13678873 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
